{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:24:29Z","timestamp":1792027469558,"version":"4.4.0"},"reference-count":44,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T00:00:00Z","timestamp":1655164800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Institutes of Health","award":["EY019014"],"award-info":[{"award-number":["EY019014"]}]},{"name":"National Institutes of Health","award":["EY301163"],"award-info":[{"award-number":["EY301163"]}]},{"name":"RWJ-Harold Amos Faculty Development Award, Research to Prevent Blindness","award":["EY019014"],"award-info":[{"award-number":["EY019014"]}]},{"name":"RWJ-Harold Amos Faculty Development Award, Research to Prevent Blindness","award":["EY301163"],"award-info":[{"award-number":["EY301163"]}]},{"name":"Paul and Evanina Mackall Foundation Trust","award":["EY019014"],"award-info":[{"award-number":["EY019014"]}]},{"name":"Paul and Evanina Mackall Foundation Trust","award":["EY301163"],"award-info":[{"award-number":["EY301163"]}]},{"name":"Center for Advanced Retinal and Ocular Therapeutics","award":["EY019014"],"award-info":[{"award-number":["EY019014"]}]},{"name":"Center for Advanced Retinal and Ocular Therapeutics","award":["EY301163"],"award-info":[{"award-number":["EY301163"]}]},{"name":"F. M. Kirby Foundation","award":["EY019014"],"award-info":[{"award-number":["EY019014"]}]},{"name":"F. M. Kirby Foundation","award":["EY301163"],"award-info":[{"award-number":["EY301163"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Optic neuritis (ON), the most common ocular manifestation of multiple sclerosis, is an autoimmune inflammatory demyelinating disease also characterized by degeneration of retinal ganglion cells (RGCs) and their axons, which commonly leads to visual impairment despite attempted treatments. Although ON disease etiology is not known, changes in the redox system and exacerbated optic nerve inflammation play a major role in the pathogenesis of the disease. Silent information regulator 1 (sirtuin-1\/SIRT1) is a ubiquitously expressed NAD+-dependent deacetylase, which functions to reduce\/prevent both oxidative stress and inflammation in various tissues. Non-specific upregulation of SIRT1 by pharmacologic and genetic approaches attenuates RGC loss in experimental ON. Herein, we hypothesized that targeted expression of SIRT1 selectively in RGCs using an adeno-associated virus (AAV) vector as a delivery vehicle is an effective approach to reducing neurodegeneration and preserving vision in ON. We tested this hypothesis through intravitreal injection of AAV7m8.SNCG.SIRT1, an AAV2-derived vector optimized for highly efficient SIRT1 transgene transfer and protein expression into RGCs in mice with experimental autoimmune encephalomyelitis (EAE), a model of multiple sclerosis that recapitulates optic neuritis RGC loss and axon demyelination. Our data show that EAE mice injected with a control vehicle exhibit progressive alteration of visual function reflected by decreasing optokinetic response (OKR) scores, whereas comparatively, AAV7m8.SNCG.SIRT1-injected EAE mice maintain higher OKR scores, suggesting that SIRT1 reduces the visual deficit imparted by EAE. Consistent with this, RGC survival determined by immunolabeling is increased and axon demyelination is decreased in the AAV7m8.SNCG.SIRT1 RGC-injected group of EAE mice compared to the mouse EAE counterpart injected with a vehicle or with control vector AAV7m8.SNCG.eGFP. However, immune cell infiltration of the optic nerve is not significantly different among all EAE groups of mice injected with either vehicle or AAV7m8.SNCG.SIRT1. We conclude that despite minimally affecting the inflammatory response in the optic nerve, AAV7m8-mediated SIRT1 transfer into RGCs has a neuroprotective potential against RGC loss, axon demyelination and vison deficits associated with EAE. Together, these data suggest that SIRT1 exerts direct effects on RGC survival and function.<\/jats:p>","DOI":"10.3390\/biom12060830","type":"journal-article","created":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T23:50:14Z","timestamp":1655250614000},"page":"830","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Selective Upregulation of SIRT1 Expression in Retinal Ganglion Cells by AAV-Mediated Gene Delivery Increases Neuronal Cell Survival and Alleviates Axon Demyelination Associated with Optic Neuritis"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7527-3121","authenticated-orcid":false,"given":"Ahmara G.","family":"Ross","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, University of Pennsylvania, Philadelphia, PA 19104, USA"},{"name":"F. M. Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA"},{"name":"Department of Neurology, University of Pennsylvania, Philadelphia, PA 19104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8516-4324","authenticated-orcid":false,"given":"Brahim","family":"Chaqour","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of Pennsylvania, Philadelphia, PA 19104, USA"},{"name":"F. M. Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devin S.","family":"McDougald","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of Pennsylvania, Philadelphia, PA 19104, USA"},{"name":"F. M. Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5569-7261","authenticated-orcid":false,"given":"Kimberly E.","family":"Dine","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of Pennsylvania, Philadelphia, PA 19104, USA"},{"name":"F. M. Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thu T.","family":"Duong","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of Pennsylvania, Philadelphia, PA 19104, USA"},{"name":"F. M. Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan E.","family":"Shindler","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of Pennsylvania, Philadelphia, PA 19104, USA"},{"name":"F. M. Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7898-8384","authenticated-orcid":false,"given":"Jipeng","family":"Yue","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of Pennsylvania, Philadelphia, PA 19104, USA"},{"name":"F. M. Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tehui","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of Pennsylvania, Philadelphia, PA 19104, USA"},{"name":"F. M. Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth S.","family":"Shindler","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of Pennsylvania, Philadelphia, PA 19104, USA"},{"name":"F. M. Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA"},{"name":"Department of Neurology, University of Pennsylvania, Philadelphia, PA 19104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,6,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.survophthal.2019.06.001","article-title":"Critical review: Typical and atypical optic neuritis","volume":"64","author":"Abel","year":"2019","journal-title":"Surv. Ophthalmol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1474-4422(17)30469-6","article-title":"Prediction of a multiple sclerosis diagnosis in patients with clinically isolated syndrome using the 2016 MAGNIMS and 2010 McDonald criteria: A retrospective study","volume":"17","author":"Filippi","year":"2018","journal-title":"Lancet Neurol."},{"key":"ref_3","first-page":"723","article-title":"Optical coherence tomography and its use in optical neuritis and multiple sclerosis","volume":"115","author":"Kemenyova","year":"2014","journal-title":"Bratisl. Lek. Listy."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Stoiloudis, P., Kesidou, E., Bakirtzis, C., Sintila, S.A., Konstantinidou, N., Boziki, M., and Grigoriadis, N. (2022). The Role of Diet and Interventions on Multiple Sclerosis: A Review. Nutrients, 14.","DOI":"10.3390\/nu14061150"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"811518","DOI":"10.3389\/fneur.2021.811518","article-title":"Molecular Mechanisms of Immunosenescene and Inflammaging: Relevance to the Immunopathogenesis and Treatment of Multiple Sclerosis","volume":"12","author":"Perdaens","year":"2021","journal-title":"Front. Neurol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1001\/archophthalmol.2012.1126","article-title":"Treatment of optic neuritis by plasma exchange (add-on) in neuromyelitis optica","volume":"130","author":"Merle","year":"2012","journal-title":"Arch. Ophthalmol."},{"key":"ref_7","first-page":"815068","article-title":"Hyperacute corticosteroid treatment of optic neuritis at the onset of pain may prevent visual loss: A case series","volume":"2011","author":"Plant","year":"2011","journal-title":"Mult. Scler. Int."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1590\/S0004-282X2012000100012","article-title":"Brazilian Committee for T, Research in Multiple S: Treatment of neuromyelitis optica: An evidence based review","volume":"70","author":"Sato","year":"2012","journal-title":"Arq. Neuropsiquiatr."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"612097","DOI":"10.3389\/fneur.2020.612097","article-title":"Remedial Effect of Intravenous Cyclophosphamide in Corticosteroid-Refractory Patients in the Acute Phase of Neuromyelitis Optica Spectrum Disorder-Related Optic Neuritis","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Neurol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3389\/fncel.2018.00377","article-title":"Intravitreal AAV-Delivery of Genetically Encoded Sensors Enabling Simultaneous Two-Photon Imaging and Electrophysiology of Optic Nerve Axons","volume":"12","author":"Looser","year":"2018","journal-title":"Front. Cell. Neurosci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jaut.2012.11.003","article-title":"Mast cell activation and neutrophil recruitment promotes early and robust inflammation in the meninges in EAE","volume":"42","author":"Christy","year":"2013","journal-title":"J. Autoimmun."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1007\/s10753-020-01242-9","article-title":"Role of Silent Information Regulator 1 (SIRT1) in Regulating Oxidative Stress and Inflammation","volume":"43","author":"Singh","year":"2020","journal-title":"Inflammation"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"109058","DOI":"10.1016\/j.exer.2022.109058","article-title":"CD38 deficiency protects the retina from ischaemia\/reperfusion injury partly via suppression of TLR4\/MyD88\/NF-kappaB signalling","volume":"219","author":"Chen","year":"2022","journal-title":"Exp. Eye. Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/978-3-319-75402-4_68","article-title":"Role of Sirtuins in Retinal Function Under Basal Conditions","volume":"1074","author":"Lin","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"778","DOI":"10.3389\/fnins.2018.00778","article-title":"Sirtuins in Neuroendocrine Regulation and Neurological Diseases","volume":"12","author":"Fujita","year":"2018","journal-title":"Front. Neurosci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1042\/BJ20070817","article-title":"Sirt1 interacts with transducin-like enhancer of split-1 to inhibit nuclear factor kappaB-mediated transcription","volume":"408","author":"Ghosh","year":"2007","journal-title":"Biochem. J."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jnutbio.2011.07.008","article-title":"Modulation of FoxO1 phosphorylation\/acetylation by baicalin during aging","volume":"23","author":"Kim","year":"2012","journal-title":"J. Nutr. Biochem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1167\/iovs.07-0131","article-title":"SIRT1 activation confers neuroprotection in experimental optic neuritis","volume":"48","author":"Shindler","year":"2007","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/WNO.0b013e3181f7f833","article-title":"Oral resveratrol reduces neuronal damage in a model of multiple sclerosis","volume":"30","author":"Shindler","year":"2010","journal-title":"J. Neuroophthalmol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1167\/iovs.17-22972","article-title":"SIRT1 and NRF2 Gene Transfer Mediate Distinct Neuroprotective Effects Upon Retinal Ganglion Cell Survival and Function in Experimental Optic Neuritis","volume":"59","author":"McDougald","year":"2018","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"5097","DOI":"10.1167\/iovs.13-12157","article-title":"SIRT1 promotes RGC survival and delays loss of function following optic nerve crush","volume":"54","author":"Zuo","year":"2013","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1089\/hum.2020.043","article-title":"Retinal Tropism and Transduction of Adeno-Associated Virus Varies by Serotype and Route of Delivery (Intravitreal, Subretinal, or Suprachoroidal) in Rats","volume":"31","author":"Han","year":"2020","journal-title":"Hum. Gene Ther."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1089\/hum.2016.111","article-title":"Evaluation of Dose and Safety of AAV7m8 and AAV8BP2 in the Non-Human Primate Retina","volume":"28","author":"Ramachandran","year":"2017","journal-title":"Hum. Gene Ther."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"7281912","DOI":"10.1155\/2019\/7281912","article-title":"Comparative AAV-eGFP Transgene Expression Using Vector Serotypes 1\u20139, 7M8, and 8b in Human Pluripotent Stem Cells, RPEs, and Human and Rat Cortical Neurons","volume":"2019","author":"Duong","year":"2019","journal-title":"Stem Cells Int."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/s41434-021-00219-z","article-title":"Rescue of retinal ganglion cells in optic nerve injury using cell-selective AAV mediated delivery of SIRT1","volume":"28","author":"Ross","year":"2021","journal-title":"Gene Ther."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1016\/j.ymthe.2017.07.011","article-title":"A New Promoter Allows Optogenetic Vision Restoration with Enhanced Sensitivity in Macaque Retina","volume":"25","author":"Chaffiol","year":"2017","journal-title":"Mol. Ther."},{"key":"ref_27","first-page":"84","article-title":"Resveratrol neuroprotection in a chronic mouse model of multiple sclerosis","volume":"3","author":"Nassrallah","year":"2012","journal-title":"Front. Neurol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3389\/fneur.2011.00050","article-title":"Optic neuritis and retinal ganglion cell loss in a chronic murine model of multiple sclerosis","volume":"2","author":"Quinn","year":"2011","journal-title":"Front. Neurol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0140-6736(16)30371-3","article-title":"Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: A follow-on phase 1 trial","volume":"388","author":"Bennett","year":"2016","journal-title":"Lancet"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0140-6736(17)30979-0","article-title":"Intravitreous injection of AAV2-sFLT01 in patients with advanced neovascular age-related macular degeneration: A phase 1, open-label trial","volume":"390","author":"Heier","year":"2017","journal-title":"Lancet"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"8936","DOI":"10.1523\/JNEUROSCI.18-21-08936.1998","article-title":"The major cell populations of the mouse retina","volume":"18","author":"Jeon","year":"1998","journal-title":"J. Neurosci."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1523\/JNEUROSCI.3714-07.2008","article-title":"Retinal ganglion cells downregulate gene expression and lose their axons within the optic nerve head in a mouse glaucoma model","volume":"28","author":"Soto","year":"2008","journal-title":"J. Neurosci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1002\/cne.23521","article-title":"The RNA binding protein RBPMS is a selective marker of ganglion cells in the mammalian retina","volume":"522","author":"Rodriguez","year":"2014","journal-title":"J. Comp. Neurol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1212\/NXI.0000000000000135","article-title":"Acute optic neuritis: Unmet clinical needs and model for new therapies","volume":"2","author":"Galetta","year":"2015","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"8882","DOI":"10.1128\/JVI.00920-08","article-title":"Experimental optic neuritis induced by a demyelinating strain of mouse hepatitis virus","volume":"82","author":"Shindler","year":"2008","journal-title":"J. Virol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3389\/fncel.2012.00063","article-title":"SIRT1 activating compounds reduce oxidative stress and prevent cell death in neuronal cells","volume":"6","author":"Khan","year":"2012","journal-title":"Front. Cell. Neurosci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1523\/JNEUROSCI.2939-14.2015","article-title":"SIRT1 deficiency in microglia contributes to cognitive decline in aging and neurodegeneration via epigenetic regulation of IL-1beta","volume":"35","author":"Cho","year":"2015","journal-title":"J. Neurosci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neulet.2013.08.020","article-title":"Protective effect of SIRT1 on toxicity of microglial-derived factors induced by LPS to PC12 cells via the p53-caspase-3-dependent apoptotic pathway","volume":"553","author":"Ye","year":"2013","journal-title":"Neurosci. Lett."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s11010-016-2837-4","article-title":"2-Deoxy glucose regulate MMP-9 in a SIRT-1 dependent and NFkB independent mechanism","volume":"423","author":"Edatt","year":"2016","journal-title":"Mol. Cell. Biochem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e1432","DOI":"10.1038\/cddis.2014.406","article-title":"Ligand-activated peroxisome proliferator-activated receptor-delta and -gamma inhibit lipopolysaccharide-primed release of high mobility group box 1 through upregulation of SIRT1","volume":"5","author":"Hwang","year":"2014","journal-title":"Cell. Death. Dis."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1002\/jcb.22858","article-title":"SIRT1 modulates high-mobility group box 1-induced osteoclastogenic cytokines in human periodontal ligament cells","volume":"111","author":"Kim","year":"2010","journal-title":"J. Cell. Biochem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"844","DOI":"10.3109\/02713683.2015.1050736","article-title":"Mangiferin Protects Retinal Ganglion Cells in Ischemic Mouse Retina via SIRT1","volume":"41","author":"Kim","year":"2016","journal-title":"Curr. Eye Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2015.03.002","article-title":"Autophagy in axonal degeneration in glaucomatous optic neuropathy","volume":"47","author":"Munemasa","year":"2015","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Zhang, Y.K., Wu, K.C., and Klaassen, C.D. (2013). Genetic activation of Nrf2 protects against fasting-induced oxidative stress in livers of mice. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0059122"}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/12\/6\/830\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:31:20Z","timestamp":1760139080000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/12\/6\/830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,14]]},"references-count":44,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,6]]}},"alternative-id":["biom12060830"],"URL":"https:\/\/doi.org\/10.3390\/biom12060830","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,14]]}}}